AbbVie Inc. SEC filings ABBV
AbbVie Inc. has 1,006 filings in SEC EDGAR's recent list, going back to May 9, 2017. Its latest annual report, Form ARS, was filed on Mar 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 2, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 11-K | Employee savings plan report | Jun 24, 2026 | Dec 31, 2025 |
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2026 | — |
| 11-K | Employee savings plan report | Jun 13, 2025 | Dec 31, 2024 |
| SD | Specialized disclosure (conflict minerals) | May 30, 2025 | — |
| 11-K | Employee savings plan report | Jun 27, 2024 | Dec 31, 2023 |
| 25-NSE | Delisting notice | Jun 3, 2024 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2024 | — |
| 25-NSE | Delisting notice | May 17, 2024 | — |
| PX14A6G | Filing | Apr 2, 2024 | — |
| PX14A6G | Filing | Mar 26, 2024 | — |
| 25-NSE | Delisting notice | Nov 15, 2023 | — |
| 11-K | Employee savings plan report | Jun 28, 2023 | Dec 31, 2022 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2023 | — |
| PX14A6G | Filing | May 4, 2023 | — |
| PX14A6G | Filing | Apr 20, 2023 | — |
| PX14A6G | Filing | Apr 11, 2023 | — |
| PX14A6G | Filing | Mar 28, 2023 | — |
| PX14A6G | Filing | Mar 28, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 20, 2022 | — |
| CORRESP | Letter to the SEC | Oct 4, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 20, 2022 | — |
| 11-K | Employee savings plan report | Jun 23, 2022 | Dec 31, 2021 |
| 11-K | Employee savings plan report | Jun 23, 2022 | Dec 31, 2021 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2022 | — |
| PX14A6G | Filing | Apr 11, 2022 | — |
| PX14A6G | Filing | Apr 4, 2022 | — |
| PX14A6G | Filing | Mar 30, 2022 | — |
| PX14A6G | Filing | Mar 25, 2022 | — |
| 11-K | Employee savings plan report | Jun 21, 2021 | Dec 31, 2020 |
| 11-K | Employee savings plan report | Jun 21, 2021 | Dec 31, 2020 |
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2021 | — |
| 25-NSE | Delisting notice | May 4, 2021 | — |
| UPLOAD | Letter from the SEC | May 4, 2021 | — |
| PX14A6G | Filing | Apr 15, 2021 | — |
| PX14A6G | Filing | Mar 31, 2021 | — |
| PX14A6G | Filing | Mar 29, 2021 | — |
| CORRESP | Letter to the SEC | Mar 19, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 16, 2021 | — |
| CORRESP | Letter to the SEC | Jan 15, 2021 | — |
| UPLOAD | Letter from the SEC | Dec 22, 2020 | — |
| CERT | Nyse certification | Nov 20, 2020 | — |
| 8-A12B | Filing | Nov 20, 2020 | — |
| EFFECT | Filing | Oct 16, 2020 | — |
| CORRESP | Letter to the SEC | Oct 14, 2020 | — |
| CORRESP | Letter to the SEC | Oct 14, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 9, 2020 | — |
| 11-K | Employee savings plan report | Jun 18, 2020 | Dec 31, 2019 |
| SD | Specialized disclosure (conflict minerals) | Jun 1, 2020 | — |
| PX14A6G | Filing | May 1, 2020 | — |
| PX14A6G | Filing | Apr 7, 2020 | — |
| PX14A6G | Filing | Mar 26, 2020 | — |
| 25-NSE | Delisting notice | Oct 18, 2019 | — |
| CERT | Nyse certification | Sep 26, 2019 | — |
| 8-A12B | Filing | Sep 26, 2019 | — |
| 11-K | Employee savings plan report | Jun 18, 2019 | Dec 31, 2018 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2019 | — |
| PX14A6G | Filing | Apr 17, 2019 | — |
| PX14A6G | Filing | Apr 1, 2019 | — |
| PX14A6G | Filing | Mar 29, 2019 | — |
| 11-K | Employee savings plan report | Jun 26, 2018 | Dec 31, 2017 |
| SC TO-I/A | Filing | Jun 4, 2018 | — |
| SD | Specialized disclosure (conflict minerals) | May 31, 2018 | — |
| SC TO-I/A | Filing | May 30, 2018 | — |
| SC TO-I/A | Filing | May 30, 2018 | — |
| SC TO-I/A | Filing | May 18, 2018 | — |
| SC TO-I/A | Filing | May 14, 2018 | — |
| CORRESP | Letter to the SEC | May 10, 2018 | — |
| SC TO-I/A | Filing | May 10, 2018 | — |
| SC TO-I/A | Filing | May 9, 2018 | — |
| SC TO-I/A | Filing | May 3, 2018 | — |
| UPLOAD | Letter from the SEC | May 2, 2018 | — |
| SC TO-I/A | Filing | May 1, 2018 | — |
| SC TO-I | Filing | May 1, 2018 | — |
| SC TO-C | Filing | Apr 26, 2018 | — |
| SC TO-C | 8-k | Apr 26, 2018 | — |
| PX14A6G | Filing | Mar 27, 2018 | — |
| PX14A6G | Filing | Mar 27, 2018 | — |
| 11-K | Employee savings plan report | Jun 28, 2017 | Dec 31, 2016 |
| SD | Specialized disclosure (conflict minerals) | May 31, 2017 | — |
Showing 79 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ABBV (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- North Chicago, IL
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1551152
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
- Pfizer Inc PFE
Source: SEC EDGAR filings. This is company-reported data, not investment advice.